SPONSOR
Bayer
Total Trials
8
Recruiting
8
Phases
Phase 1, Phase 2, Phase 4
Conditions studied: SepsisCoagulopathyAdvanced or Recurrent Solid Tumor Harboring an NTRK Gene FusionHigh-Risk Localized Prostate CancerRetinopathy of PrematurityPreterm InfantsGastroesophageal RefluxTransthyretin Amyloid CardiomyopathyMetastatic Hormonesensitive Prostate Cancer (mHSPC)Prostate Cancer
Bayer is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including Sepsis, Coagulopathy, Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion, High-Risk Localized Prostate Cancer.
The trial portfolio spans Phase 1, Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Bayer
How many clinical trials has Bayer sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by Bayer, of which 8 are actively recruiting participants. These trials cover conditions including Sepsis, Coagulopathy, Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Bayer research focus on?
Bayer clinical trials span Sepsis, Coagulopathy, Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion, High-Risk Localized Prostate Cancer, Retinopathy of Prematurity, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Bayer clinical trial?
To participate in a Bayer trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Bayer trials with current recruitment status updated daily.
Clinical Trials by Bayer
NCT06854640 Phase 1
Recruiting
A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy
Sepsis
NCT04945330
Recruiting
NTRK Gene Fusion - Positive Advanced or Recurrent Solid Tumors, a Rare Cancer Caused by Specific Changes in the Genes
Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
NCT07450599 Phase 2
Recruiting
A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.
High-Risk Localized Prostate Cancer
NCT06315556
Recruiting
An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)
Retinopathy of Prematurity
NCT07291700
Recruiting
Study on Hydrotalcite for Relief of Acid Symptoms Due to Acid Rebound After Stopping Long-Term PPI Therapy
Gastroesophageal Reflux
NCT07298044 Phase 4
Recruiting
A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis
Transthyretin Amyloid Cardiomyopathy
NCT07223372
Recruiting
An Observational Study to Learn More About How Medicines That Block Male Hormones Are Used in People With Prostate Cancer in Australia
Metastatic Hormonesensitive Prostate Cancer (mHSPC)
NCT07672119
Recruiting
A Study to Learn About Heart-Related Risks in Elderly Men With Advanced Prostate Cancer Treated With Enzalutamide or Darolutamide
Prostate Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology